FBIOP Latest Press Releases

-- November 13, 2026 --

Fortress Biotech Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 8:00 AM

-- November 10, 2026 --

Fortress Biotech Announces an Exclusive License Agreement for FB-607 for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) Globe Newswire 4:05 PM

-- September 8, 2026 --

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 8:00 AM

-- August 13, 2026 --

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- July 27, 2026 --

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $130 Million Series B Financing Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes